These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2787000)

  • 21. [Initial evaluation of aluminum concentrations in patients with nephropathy and undergoing hemodialysis at the Miguel Pérez Carreño Hospital and the University Hospital of Caracas (Venezuela)].
    Parra OE; Navarro JA; de Ardila M; Weissinger J; Domínguez J; Gutiérrez LE; Carlini R; Mendoza JA; Salgado OJ; Romero RA
    Invest Clin; 1989; 30(4):193-203. PubMed ID: 2488708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of the serum aluminum values in the Piedmont dialysis population. Dialysis Centers of the Piedmont].
    Fidelio T; Licata C; Serra A; Scalzo B; Deabate MC; Sancipriano GP; Iacono G; Calitri V
    Minerva Urol Nefrol; 1994 Mar; 46(1):73-6. PubMed ID: 8036558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years.
    Fernández-Martín JL; Canteros A; Serrano M; González-Carcedo A; Díaz-Corte C; Cannata Andía JB
    Nephrol Dial Transplant; 1998; 13 Suppl 3():78-81. PubMed ID: 9568827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT; Milliner DS; Johnson WJ
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era].
    Arenas MD; Malek T; Gil MT; Moledous A; Núñez C; Alvarez-Ude F
    Nefrologia; 2008; 28(2):168-73. PubMed ID: 18454706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of high serum aluminium in a patient on maintenance haemodialysis.
    Wallace MR
    N Z Med J; 1981 May; 93(684):335-7. PubMed ID: 6942294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
    Wallace MR; Pybus J
    N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of aluminium in patients with acute renal failure.
    Davenport A; Roberts NB
    Nephron; 1989; 52(3):253-8. PubMed ID: 2739864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aluminium in water for preparation of dialysate and in serum of dialysed patients.
    Blanusa M; Prester L; Crnogorac M; Puretić Z; Bubić-Filipi L; Dadić Z
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):197-204. PubMed ID: 9434431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide.
    Slanina P; Falkeborn Y; Frech W; Cedergren A
    Food Chem Toxicol; 1984 May; 22(5):391-7. PubMed ID: 6539288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM; Walker GS; Oli H; Lewins AM
    Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.
    Barata JD; D'Haese PC; Pires C; Lamberts LV; Simões J; De Broe ME
    Nephrol Dial Transplant; 1996 Jan; 11(1):125-32. PubMed ID: 8649620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of aluminium on the effect of 1 alpha (OH)D3 on renal osteodystrophy.
    Shimada H; Nakamura M; Marumo F
    Nephron; 1983; 35(3):163-70. PubMed ID: 6633756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients].
    Kiss D; Battegay M; Meier C; Lyrer A
    Schweiz Med Wochenschr; 1990 Mar; 120(9):295-8. PubMed ID: 2315655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.